This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $55.50, marking a +1% move from the previous day.
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
by Benjamin Rains
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
Why Is CVS Health (CVS) Down 7.9% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $56.16, moving -1.63% from the previous trading session.
Amazon's HSA & FSA Payment Option to Boost Pharma Initiatives
by Zacks Equity Research
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.
Pivotal Software (PVTL) Q4 Loss Narrows, Revenues Up Y/Y
by Zacks Equity Research
Pivotal Software (PVTL) fourth-quarter fiscal 2019 results benefit from growth in subscription revenues on the back of increase in customers and services adoption.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $55.88 in the latest trading session, marking a -1.22% move from the prior day.
Buy Amazon (AMZN) Stock on Earnings Growth & E-commerce Dominance?
by Benjamin Rains
Amazon (AMZN) shares have climbed roughly 13% to start the year, which tops the market's comeback, but falls way behind fellow FAANG giants Facebook (FB) and Netflix (NFLX). Therefore, Amazon stock still rests over 17% below its 52-week high.
CVS Health Stock Jumps on Bullish Coverage: Time to Buy?
by Benjamin Rains
Shares of CVS Health (CVS) surged over 4% through mid-afternoon trading Wednesday on the back of a bullish call from Bernstein analysts. The drugstore chain is also coming off a stronger-than-expected fourth quarter. So, is now the time to buy CVS stock?
New Strong Sell Stocks for March 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $52.93, marking a +1.08% move from the previous day.
Buy Target (TGT) Stock After Q4 Earnings on E-Commerce Growth?
by Benjamin Rains
Shares of Target (TGT) surged over 4.5% Tuesday after it reported its fourth quarter financial results before the opening bell. The climb helped continue the retail power's strong 2019. So is now the time to buy shares of TGT as it proves that its e-commerce investments have paid off.
What to Expect from Kroger (KR) Earnings as Amazon Expands Grocery Business
by Benjamin Rains
Let's see what to expect from Kroger's fourth-quarter financial results that are due out Thursday, with Amazon (AMZN) set to roll out its own branded grocery store-style offerings.
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
CVS Health Rides on Aetna Synergy, PBM Selling Season Modest
by Zacks Equity Research
With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Company News For Feb 21, 2019
by Zacks Equity Research
Companies in the news are: CVS, CDNS, GRMN and OC
Fed Minutes & Q4 Earnings
by Zacks Equity Research
Fed Minutes & Q4 Earnings
CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up
by Zacks Equity Research
CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
Fed Minutes, More Q4 Earnings Expected; Plus CVS, SO
by Mark Vickery
Odds are there will be no quarter-point raise until June of this year at the earliest. But what today's minutes may expose is where the fault lines among FOMC members lie.
CVS Health (CVS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 3.38% and 1.34%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
CVS Health Stock Pops Before Q4 Earnings: What to Expect
by Benjamin Rains
Let's see what to expect from CVS' fourth-quarter financial results that are due out before the opening bell Wednesday.
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Should Value Investors Pick CVS Health (CVS) Stock Now?
by Zacks Equity Research
Let's see if CVS Health Corporation (CVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
What's in the Cards for Genomic Health (GHDX) in Q4 Earnings?
by Zacks Equity Research
Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4.